Comparing clinical symptoms and bacterial features in irritable bowel syndrome (IBS) patients with and without small intestine bacterial overgrowth (SIBO).
Not Applicable
- Conditions
- Irritable bowel syndrome (IBS)Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
- Registration Number
- ACTRN12616001162404
- Lead Sponsor
- Dunedin School of Medicine, University of Otago
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Stopped early
- Sex
- All
- Target Recruitment
- 220
Inclusion Criteria
Participants with IBS (D) or IBS (M) according to Rome III criteria who are fluent in English. Healthy controls are female and male, aged 18-65 with no gastrointestinal physiology and fluent in English.
Exclusion Criteria
Organic gastrointestinal disease (e.g. coeliac, IBD),
Diabetes,
Serious neurological or respiratory conditions
Previous gastrointestinal surgery (except appendectomy),
Pancreatitis,
Previous radiotherapy to the abdominal area or chemotherapy,
Pregnancy and lactation,
Antibiotics or probiotics within the last 6 weeks,
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method